Mark Nowakowski

Mark Nowakowski Email and Phone Number

CEO and Founder @ Digital FluiDx
San Diego, CA, US
Mark Nowakowski's Location
San Diego, California, United States, United States
About Mark Nowakowski

Mark Nowakowski is a CEO and Founder at Digital FluiDx. He possess expertise in biotechnology, assay development, dna, r&d, protein purification and 6 more skills.

Mark Nowakowski's Current Company Details
Digital FluiDx

Digital Fluidx

View
CEO and Founder
San Diego, CA, US
Mark Nowakowski Work Experience Details
  • Digital Fluidx
    Ceo And Founder
    Digital Fluidx
    San Diego, Ca, Us
  • Phase Two Ventures
    Venture Partner
    Phase Two Ventures May 2023 - Present
  • Argonaut Manufacturing Services Inc.
    Board Member
    Argonaut Manufacturing Services Inc. Mar 2023 - Present
    Carlsbad, Ca, Us
  • Argonaut Manufacturing Services Inc.
    Chief Technology Officer
    Argonaut Manufacturing Services Inc. Jul 2018 - Mar 2024
    Carlsbad, Ca, Us
  • Defined Bioscience
    Scientific Advisor
    Defined Bioscience Jul 2021 - Present
    San Diego, Ca, Us
  • Lyogen Llc
    Chief Executive Officer And Founder
    Lyogen Llc Oct 2011 - Jul 2018
  • Mesa Tech International, Inc.
    Chief Operating Officer
    Mesa Tech International, Inc. Oct 2011 - Mar 2016
    San Diego, California, Us
    Mesa Tech International, Inc. (MTI) seeks to commercialize technologies to reduce the complexity and cost of nucleic acid-based molecular diagnostics (MDx). MTI’s goal is to replace complex, time-consuming and expensive laboratory-based MDx tools. MTI’s proprietary and patented technology, already implemented in working prototypes and in pilot production, yields tremendous cost, time and complexity reductions for MDx that allow such tests to be completed within 30 minutes at the point-of-care (POC), without the need to send samples to outside laboratories. The MTI platform includes easy-to-use, inexpensive handheld units and disposable reagent cards, which will make MDx-based infectious disease and cancer screening far more accessible and affordable to diverse end-users and which will open promising new markets. Initially, these products will be sold to physicians and physician assistants for use in offices, clinics and hospitals. Eventually, MDx in MTI formats could become available to individual consumers at home, making such molecular tests as common as today’s widely used home pregnancy tests.
  • Biomatrix Engineering Inc.
    Principal Development Engineer And Founder
    Biomatrix Engineering Inc. Jan 1998 - Nov 2011
    Development and scale-up of medical in-vitro diagnostic platforms for the detection of disease. Responsible for the design and automated manufacture of disposable, injection molded diagnostic microfluidic cartridges, development of various labels for point-of-care assays, and the scale-up of all chemical processes. Development and lyophilization of reagents including bulk, vials, and bead formats.
  • Fmc Bioproducts
    Principal Development Engineer
    Fmc Bioproducts 1992 - 1997
    Developed and scaled-up a series of precast agarose and polyacrylamide gels for DNA, RNA, and protein separation.
  • Biosite Diagnostics
    Director Of Engineering
    Biosite Diagnostics Oct 1987 - Oct 1992
    Developed a patented in-vitro diagnostic device for the screening of drugs-of-abuse. Included immobilization of multiple test zones on an artificial membrane, design and optimization of an injection molded device, developed a lyophilization process for unit dose, room stabile antibody, label, and buffer beads, developed a method for self-mixing of the reconstituted components, and automated processes and assembly of the final product.
  • Hybritech Inc.
    Sr. Engineer
    Hybritech Inc. 1985 - 1987

Mark Nowakowski Skills

Biotechnology Assay Development Dna R&d Protein Purification Molecular Biology Protein Chemistry Infectious Diseases Molecular Diagnostics Immunoassays In Vitro

Mark Nowakowski Education Details

  • University Of Southern California
    University Of Southern California
    Ms In R&D Systems Management

Frequently Asked Questions about Mark Nowakowski

What company does Mark Nowakowski work for?

Mark Nowakowski works for Digital Fluidx

What is Mark Nowakowski's role at the current company?

Mark Nowakowski's current role is CEO and Founder.

What is Mark Nowakowski's email address?

Mark Nowakowski's email address is br****@****ail.com

What is Mark Nowakowski's direct phone number?

Mark Nowakowski's direct phone number is +185844*****

What schools did Mark Nowakowski attend?

Mark Nowakowski attended University Of Southern California.

What skills is Mark Nowakowski known for?

Mark Nowakowski has skills like Biotechnology, Assay Development, Dna, R&d, Protein Purification, Molecular Biology, Protein Chemistry, Infectious Diseases, Molecular Diagnostics, Immunoassays, In Vitro.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.